Defective proviruses rapidly accumulate during acute HIV-1 infection

Cited by (745)

Items 501–600 of 745

1. Persistence of envelopes in different CD4+ T-cell subsets in antiretroviral therapy-suppressed people with HIV
   Matthew J. Gartner, Carolin Tumpach, Ashanti Dantanarayana, Jared Stern, Jennifer M. Zerbato, J. Judy Chang, Thomas A. Angelovich, Jenny L. Anderson, Jori Symons, Steven G. Deeks et al. · 2022 · AIDS
2. Kangaroo endogenous retrovirus (KERV) forms megasatellite DNA with a simple repetition pattern in which the provirus structure is retained
   Akihiko Koga, Hidenori Nishihara, Hideyuki Tanabe · 2023 · Virology
3. A cure for HIV: how would we know?
   Jennifer M. Zerbato, Sharon R. Lewin · 2020 · The Lancet HIV
4. Quantitative Viral Outgrowth Assay to Measure the Functional SIV Reservoir in Myeloid Cells
   Celina Monteiro Abreu, Rebecca T. Veenhuis, Erin N. Shirk · 2022 · Methods in molecular biology
5. Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals
   Xiao Qian Wang, Jennifer M. Zerbato, Anchalee Avihingsanon, Katie Fisher, Timothy E. Schlub, Ajantha Rhodes, Jennifer Audsley, Kasha Priya Singh, Wei Dong Zhao, Sharon R. Lewin et al. · 2022 · Journal of Virology
6. TZA: a novel assay for measuring the latent HIV-1 reservoir
   Phalguni Gupta, Anwesha Sanyal, Robbie B. Mailliard · 2017 · Expert Review of Molecular Diagnostics
7. Revealing viral and cellular dynamics of HIV-1 at the single-cell level during early treatment periods
   Otte, Fabian, Zhang, Yuepeng, Spagnuolo, Julian, Thielen, Alexander, Däumer, Martin, Wiethe, Carsten, Stoeckle, Marcel, Kusejko, Katharina, Klein, Florian, Metzner, Karin J. et al. · 2023 · Cell Reports Methods
8. Distinguishing active HIV-1 infection from vaccine-induced seropositivity in HIV vaccine trial participants
   Ketan Dighe, Oğuzhan Çolak, Parikshit Moitra et al. · 2025 · Science Advances
9. Epigenetic Compound Screening Uncovers Small Molecules for Reactivation of Latent HIV-1
   Ariane Zutz, Lin Chen, Franziska Sippl · 2020 · Antimicrobial Agents and Chemotherapy
10. Harnessing Novel Imaging Approaches to Guide HIV Prevention and Cure Discoveries—A National Institutes of Health and Global HIV Vaccine Enterprise 2017 Meeting Report
    Brigitte E. Sanders-Beer, Yegor Voronin, David McDonald · 2017 · AIDS Research and Human Retroviruses
11. Quantitative Evaluation of Very Low Levels of HIV-1 Reverse Transcriptase by a Novel Highly Sensitive RT-qPCR Assay
    Francesca Marino‐Merlo, Valeria Stefanizzi, Agnese Ragno · 2022 · Life
12. Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial
    Fella Mazouz, Mélanie Bertine, Romain Coppée et al. · 2023 · Journal of Antimicrobial Chemotherapy
13. Machine learning approaches identify immunologic signatures of total and intact HIV DNA during long-term antiretroviral therapy
    Lesia Semenova, Yingfan Wang, Shane D. Falcinelli · 2024 · eLife
14. HIV Cure: How Far We Have Come?
    Shesh Prakash Maurya, Abhishek Shrivastav, Vivek Singh Rawat, Hitender Gautam, Bimal Kumar Das · 2024 · Indian Journal of Microbiology
15. Human models that inform antiretroviral therapy-free remission with perinatally acquired HIV infection
    Caroline T. Tiemessen · 2025 · Current Opinion in HIV and AIDS
16. The Antiviral Immune Response and Its Impact on the HIV-1 Reservoir
    Rebecca T. Veenhuis, Joel N. Blankson · 2017 · Current topics in microbiology and immunology
17. In vivo Serial Passaging of Human–Simian Immunodeficiency Virus Clones Identifies Characteristics for Persistent Viral Replication
    Rajesh Thippeshappa, Patricia S. Polacino, S Chandrasekar, Khanghy Truong, Anisha Misra, Paula C. Aulicino, Shiu‐Lok Hu, Deepak Kaushal, Jason T. Kimata · 2021 · Frontiers in Microbiology
18. HIV drug resistance in various body compartments
    Gert Uves van Zyl, Jeffrey R. Dorfman, Mary F. Kearney · 2022 · Current Opinion in HIV and AIDS
19. Evaluating the Dual-Target Aptima HIV-1 Quant Dx Assay: Comparison between Viral Loads Measured with pol and LTR Targets in the Same Samples
    Giuseppe Sberna, Silvia Sarti, Stefania Cicalini · 2022 · Microbiology Spectrum
20. Predictors of intact HIV DNA levels among children in Kenya
    Jillian Neary, Carolyn S. Fish, Noah A.J. Cassidy, Dalton C. Wamalwa, Agnes Langat, Evelyn W. Ngugi, Sarah F. Benki-Nugent, Hellen Moraa, Barbra A. Richardson, Irene N Njuguna et al. · 2023 · AIDS
21. Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I
    Maria Yousefi, Arun Kumar Annan Sudarsan, Amit Gaba · 2023 · Viruses
22. Assessing the Impact of Persistent HIV Infection on Innate Lymphoid Cells Using In Vitro Models
    Aude Boulay, Sara Trabanelli, Stéphanie Boireau, Myriam Boyer-Clavel, Sébastien Nisole, Pedro J. Romero, Camilla Jandus, Anne‐Sophie Beignon, Nathalie Jane Arhel · 2023 · ImmunoHorizons
23. The build-up of stock of stable integrated proviruses overtime explains the difficulty in reducing HIV-1 DNA levels when treatment is initiated at the chronic stage of the infection
    Gilbert Mchantaf, Antoine Chéret, Adeline Mélard et al. · 2023 · Journal of Virus Eradication
24. A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency
    Caroline C. Garliss, Abena K. Kwaa, Joel N. Blankson · 2020 · Open Forum Infectious Diseases
25. Hepatitis C Virus Influences HIV-1 Viral Splicing in Coinfected Patients
    Paula Martínez-Román, María Rosa López‐Huertas, Celia Crespo‐Bermejo, Sonia Arca-Lafuente, Isabel Cortegano, Daniel Valle‐Millares, Marı́a-Luisa Gaspar, Luz Martín‐Carbonero, Lourdes Domínguez, Pablo Ryan et al. · 2020 · Journal of Clinical Medicine
26. Utility of Integrated HIV-1 Dna Quantification in Cure Studies
    Alessandra Ruggiero, Eva Malatinková, Sofie Rutsaert, William A. Paxton, Linos Vandekerckhove, Ward De Spiegelaere · 2017 · Future Virology
27. Quantifying the clonality and dynamics of the within-host HIV-1 latent reservoir
    Roux-Cil Ferreira, Jessica L. Prodger, Andrew D. Redd, Art F. Y. Poon · 2020 · Virus Evolution
28. FISHing Out the Hidden Enemy: Advances in Detecting and Measuring Latent HIV-Infected Cells
    Vinayaka R. Prasad, Ganjam V. Kalpana · 2017 · mBio
29. HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation
    Lynn Tyers, Matthew Moeser, Jean Felistas Ntuli, Shuntai Zhou, E. Spielvogel, Amy Sondgeroth, Craig H. Adams, Ruwayhida Thebus, Anna Yssel, Salim S. Abdool Karim et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
30. Single-cell characterization of the gastrointestinal HIV reservoir reveals heterogeneous cellular phenotypes
    Peterson, Jackson J., Chandel, Shipra, James, Katherine, Bennett, Elizabeth S., Wu, Vincent, White, Cory H., Allard, Brigitte, Clohosey, Matthew, Whitaker, Taylor, Baker, Caroline et al. · 2026 · Journal of Clinical Investigation
31. From natural defenders to therapeutic warriors: NK cells in HIV immunotherapy
    Thessa Laeremans, A Janssens, Joeri L. Aerts · 2025 · Immunotherapy
32. Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure
    Joshua Tisdell Schiffer, Joseph C. Mudd, Annukka A.R. Antar, Adam M. Spivak, Daniel B. Reeves · 2025 · Journal of Virology
33. Mu opioid receptor activation in microglia enhances HIV-1 infection and HIV-infection-induced inflammatory responses
    Chelsey A. Skeete, Gabriel Sgambettera, Aldana D. Gojanovich, Xianbao He, Daniel Bryant, Mengwei Yang, Shreya Banerjee, Andrés A. Quiñones-Molina, Hisashi Akiyama, Gustavo Mostoslavsky et al. · 2025 · Frontiers in Immunology
34. Tools to Quantify and Characterize the Persistent Reservoir in People with HIV-1: Focus on Non-B Subtypes
    Zora Sinay, Annefien Tiggeler, Robert-Jan T. S. Palstra, Tokameh Mahmoudi · 2026 · Viruses
35. Chronic inflammation in virus-suppressed people living with human immunodeficiency virus infection: A microbiology-oriented perspective on gut barrier failure, microbial translocation, and immune activation
    Yusuke Yoshino, Yoshitaka Kimura, Fuyu Ito · 2026 · Journal of Infection and Chemotherapy
36. Detection of Inducible Replication-Competent HIV-1 Subtype C Provirus Despite Long-Term Antiretroviral Treatment in Perinatally Infected Adolescents in Botswana
    Catherine Kegakilwe Koofhethile, Sikhulile M. Moyo, Kenanao Peggy Kotokwe et al. · 2020 · AIDS Research and Human Retroviruses
37. Systemic and Intestinal Viral Reservoirs in CD4+ T Cell Subsets in Primary SIV Infection
    Xiaolei Wang, Widade Ziani, Ronald S. Veazey, Huanbin Xu · 2021 · Viruses
38. Current methods for detecting and assessing HIV-1 antibody resistance
    Stanley Odidika, Martin Pirkl, Thomas Lengauer, Philipp Schommers · 2025 · Frontiers in Immunology
39. Exploring the mechanisms of interference, persistence and antiviral potential of defective interfering particles
    Mousumi Bora, M. Manu, Monu Karki · 2025 · Discover Viruses.
40. Expression of HIV from a 1-LTR circular DNA in the absence of integration
    Corrado Gurgo, Claudio Fenizia, Katherine M. McKinnon, Ru‐ching Hsia, Genoveffa Franchini · 2025 · Retrovirology
41. A First-in-Class Dual Degrader of Bcl-2/Bcl-xL Reverses HIV Latency and Minimizes Ex Vivo Reservoirs from Patients
    Lin-Chun Chang, Michael T. Yin, Gregory M. Laird, Kristen D. Ritter, Jayesh Shah, Asim Kumar Debnath · 2025 · International Journal of Molecular Sciences
42. A Model of Non-Homologous Recombination Mediated by HIV-1 Reverse Transcriptase Explaining Sequence Motif Duplications That Confer a Replication Fitness Advantage
    Arun Panchapakesan, Udaykumar Ranga · 2025 · Viruses
43. The immunophenotype and proviral landscape of HIV-infected CD4 T cells during antiretroviral therapy
    Cyrille L. Delley, Sakshi Shah, Kevin M. Joslin, Yujung P. Park, Benjamin Demaree, Michael Paul Busch, Mars Stone, Steven G. Deeks, Eli Boritz, Adam R. Abate et al. · 2026 · Proceedings of the National Academy of Sciences
44. Differential decreases in various HIV DNA regions and HIV transcripts after ART initiation during chronic infection
    Julie Janssens, Cordelia Isbell, Sun Jin Kim et al. · 2025 · Journal of Virology
45. Increased T cell trafficking as adjunct therapy for HIV-1
    Helen R. Fryer, Steven M. Wolinsky, Angela Ruth McLean · 2018 · PLoS Computational Biology
46. Viral evolution in the cell‐associated HIV‐1 DNA during early ART can lead to drug resistance and virological failure in children
    Bindu Parachalil Gopalan, Reena R. D’Souza, Niharika Rajnala · 2019 · Journal of Medical Virology
47. Highlights from the Third Biennial Strategies for an HIV Cure Meeting
    Diane M. P. Lawrence, Lillian S. Kuo, Elizabeth Chandler Church · 2017 · Journal of Virus Eradication
48. HIV‐1 proviral landscape characterization varies by pipeline analysis
    Fernanda A Ferreira, Qianjing He, Stephanie Banning · 2021 · Journal of the International AIDS Society
49. Nanoscale probing and imaging of HIV-1 RNA in cells with a chimeric LNA–DNA sensor
    Alessia Amodio, Marco Cassani, Liviana Mummolo et al. · 2022 · Nanoscale
50. Targeted plasma proteomics identifies MICA and IL1R1 proteins associated with HIV-1 reservoir size
    Marc J. T. Blaauw, Jéssica Cristina dos Santos, Nadira Vadaq, Wim Trypsteen, Wouter van der Heijden, Albert L. Groenendijk, Zhenhua Zhang, Yang Li, Quirijn de Mast, Mihai Gheorghe Netea et al. · 2023 · iScience
51. Human immunodeficiency virus 1 5′-leader mutations in plasma viruses before and after the development of reverse transcriptase inhibitor-resistance mutations
    Janin Nouhin, Philip L. Tzou, Soo‐Yon Rhee · 2023 · Journal of General Virology
52. Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus
    Ryan Yucha, Morgan L. Litchford, Carolyn S. Fish, Zak A. Yaffe, Barbra A. Richardson, Elizabeth Maleche‐Obimbo, Grace C. John-Stewart, Dalton C. Wamalwa, Julie M. Overbaugh, Dara A. Lehman · 2023 · Viruses
53. ‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence
    Alexander O. Pasternak, Tetsuo Tsukamoto, Ben Berkhout · 2023 · AIDS
54. A novel high-throughput microwell outgrowth assay for HIV-infected cells
    Anthony D. Fenton, Nancie M. Archin, Anne‐Marie W. Turner · 2024 · Journal of Virology
55. Quantitative and Qualitative Distinctions between HIV-1 and SIV Reservoirs: Implications for HIV-1 Cure-Related Studies
    Joseph C. Mudd · 2024 · Viruses
56. Leveraging Novel Integrated Single-Cell Analyses to Define HIV-1 Latency Reversal
    Suhui Zhao, Athe M. N. Tsibris · 2021 · Viruses
57. Quantification of total HIV-1 DNA in buffy coat cells, feasibility and potential added value for clinical follow-up of HIV-1 infected patients on ART
    Virginie Mortier, Els Demecheleer, Delfien Staelens · 2018 · Journal of Clinical Virology
58. Retroviruses and reproduction revisited
    Ann Anderson Kiessling · 2018 · Journal of Assisted Reproduction and Genetics
59. HIV DNA decay during antiretroviral therapy
    Nikolaus Jilg, Peter W. Hunt, Rajesh Tim Gandhi · 2018 · AIDS
60. Bilateral proptosis caused by orbital myositis: a case report
    Kürşad Aydın, Nazmi Narın, Kuddusi Erkılıç, Selim Kurtoğlu, I Hallac, Hakan Poyrazoğlu · 1998 · The Turkish Journal of Pediatrics
61. Can a Traditional Chinese Medicine Contribute to a Cure for HIV?
    Thomas J. Hope · 2017 · AIDS Research and Human Retroviruses
62. Dendritic cells as natural latency reversing agent: A wake-up call for HIV-1
    Thijs van Montfort, Dave Speijer, Ben Berkhout · 2017 · Virulence
63. Droplet microfluidic sequencing of HIV genomes and integration sites
    Chen Sun, Leqian Liu, Liliana Pérez, Xiangpeng Li, Yifan Liu, Peng Xu, Eli Boritz, James I. Mullins, Adam R. Abate · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
64. The replication-competent HIV reservoir is a genetically restricted, younger subset of the overall pool of HIV proviruses persisting during therapy, which is highly genetically stable over time
    Aniqa Shahid, Signe MacLennan, Bradley R. Jones, Hanwei Sudderuddin, Zhong Dang, Kyle D. Cobarrubias, Maggie C. Duncan, Natalie N. Kinloch, Michael J. Dapp, Nancie M. Archin et al. · 2023 · Research Square
65. Comparison of HIV-1 DNA load measurements in blood and in relation to successful proviral sequencing
    Anne Fuchs, Antoine Wasser, Clayton Faua et al. · 2023 · Infectious Diseases Now
66. Learning From Full Characterization of HIV Proviruses in People Receiving Long-Acting Cabotegravir/Rilpivirine With a History of Replication on the Antiretroviral Classes
    Gilbert Mchantaf, Antoine Chaillon, Caroline Charre, Adeline Mélard, Elise Gardiennet, Jérôme Guinard, Thiérry Prazuck, Clémence Guillaume, Alice‐Andrée Mariaggi, Julie Bois et al. · 2024 · Open Forum Infectious Diseases
67. Aberrant DNA methylation of genes regulating CD4+ T cell HIV‐1 reservoir in women with HIV
    Ke Xu, Xinyu Zhang, Kesava R. Asam, Bryan C. Quach, Grier P. Page, Deborah J. Konkle‐Parker, Claudia A. Martinez, Cecile Delille Lahiri, Elizabeth F. Topper, Mardge H. Cohen et al. · 2025 · Clinical and Translational Medicine
68. Limitations and use of the Morpheus-V5 dual reporter virus in assessing interventions that target HIV latency
    Kiho Tanaka, Youry Kim, Jesslyn Ong · 2025 · Journal of Virological Methods
69. Molecular characterization of HIV-1 near-full-length proviral quasispecies in monocytes from patients across different virological responses
    Jian Li, Chuyu Zhang, Zhenyi Zou et al. · 2025 · Frontiers in Microbiology
70. HIV protein Nef expression in human microglia drives the release of distinct Nef-containing extracellular vesicles
    Teja Lavrin, Jure Loboda, Jana Ferdin, Valentina Levak, Simona Sitar, Marija Holcar, Nataša Resnik, Matjaž Stenovec, Alenka Trampuš Bakija, Peter Veranič et al. · 2025 · Extracellular Vesicles and Circulating Nucleic Acids
71. The Differentially Regulated Cousins: Insights into the Differences in Transcriptional Regulatory Mechanisms Between HTLV-1 and HIV-1
    Omnia Reda, Yorifumi Satou · 2026 · Viruses
72. Dynamics of Intact and Defective Human Immunodeficiency Virus Type 1 (HIV-1) Proviruses During Decades of Suppressive Antiretroviral Treatment in Young Adults With Perinatal HIV
    Priya Khetan, Kunjal Patel, Wendy Yu · 2026 · The Journal of Infectious Diseases
73. Non-suppressible HIV viremia sustained by clonally expanded CD4+ T cells harboring a genomically defective provirus with an immune-evasive protein expression profile
    F. Harrison Omondi, Yurou Sang, Winnie W. Y. Dong, Francis M. Mwimanzi, Peter K. Cheung, Evan Barad, Zerufael Derza, Kieran Anderson, Aniqa Shahid, Vitaliy Mysak et al. · 2026 · mBio
74. Dynamics of latent HIV under clonal expansion
    John Michael Murray · 2021 · PLoS Pathogens
75. Viral Persistence in the Gut-Associated Lymphoid Tissue and Barriers to HIV Cure
    Francesca Cossarini, Judith A. Aberg, Benjamin K. Chen, Saurabh Mehandru · 2023 · AIDS Research and Human Retroviruses
76. Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, Uganda
    Edward Nelson Kankaka, Andrew D. Redd, Amjad Khan, Steven James Reynolds, Sharada Saraf, Charles S. Kirby, Briana A. Lynch, Jada Hackman, Stephen Tomusange, Taddeo Kityamuweesi et al. · 2023 · Virus Evolution
77. Virological characterization of HIV-1 RNA elements detected exclusively through the LTR region by the dual-target Aptima HIV-1 Quant Dx assay in a subset of positive patients
    Giuseppe Sberna, Roberta Nardacci, Giulia Berno, Gabriella Rozera, Emanuela Giombini, Lavinia Fabeni, Eliana Specchiarello, Fabrizio Maggi, Alessandra Amendola · 2023 · Journal of Clinical Virology
78. Distinguishable topology of the task-evoked functional genome networks in HIV-1 reservoirs
    Janusz Wisniewski, Kamil Więcek, Haider Ali, Krzysztof Pyrć, Anna Kula, Marek Wagner, Heng‐Chang Chen · 2024 · iScience
79. An Immunocytochemistry Method to Investigate the Translationally Active HIV Reservoir
    Guoxin Wu, Samuel H. Keller, Ryan T. Walters et al. · 2025 · International Journal of Molecular Sciences
80. Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy
    Jenna M. Hasson, Mary Grace Katusiime, Adam A. Capoferri, Michael J. Bale, Brian T. Luke, Wei Shao, Mark Fredric Cotton, Gert Uves van Zyl, Sean C. Patro, Mary F. Kearney · 2025 · Viruses
81. HIV persistence in the CNS: the final frontier for a cure?
    Sharon R. Lewin, John W. Mellors · 2016 · Journal of Virus Eradication
82. Bayesian phylogenetic inference of HIV latent lineage ages using serial sequences
    Anna A. Nagel, Bruce H. Rannala · 2023 · Journal of The Royal Society Interface
83. A New Agent in the Strategy to Cure AIDS
    John A. Zaia · 2016 · Molecular Therapy
84. HIV: Persistence through division
    Lillian B. Cohn, Michel C. Nussenzweig · 2017 · The Journal of Experimental Medicine
85. Novel assays to investigate the mechanisms of latent infection with HIV-2
    Michael D. Lu, Sushama Telwatte, Nitasha Kumar et al. · 2022 · PLoS ONE
86. Advances in HIV Eradication Strategies
    Qingmin Mei, Wei Wang, Jianjun Wu, Yong Gao · 2022 · Infectious Microbes & Diseases
87. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity
    Fareeda M. Barzak, Timothy M. Ryan, Nazanin Mohammadzadeh et al. · 2022 · Viruses
88. Controversies in the Design of Strategies for the Cure of HIV Infection
    Alejandro de Gea Grela, Santiago Moreno · 2023 · Pathogens
89. Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G
    Krista A. Delviks‐Frankenberry, Chet Raj Ojha, Kip J. Hermann · 2023 · Molecular Therapy — Nucleic Acids
90. Neutralization and beyond: Antibodies and HIV-1 acquisition.
    Allison S. Thomas, Melissa Ghulam-Smith, Manish Sagar · 2018 · PubMed
91. A majority of HIV persistence during antiretroviral therapy is due to infected cell proliferation
    Daniel B. Reeves, Elizabeth R. Duke, Thor A. Wagner, Sarah Palmer, Adam M. Spivak, Joshua T. Schiffer · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
92. Full-coverage native RNA sequencing of HIV-1 viruses
    Alejandro Rafael Gener, Jason T. Kimata · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
93. Single-cell immune profiling reveals the impact of antiretroviral therapy on HIV-1-induced immune dysfunction, T cell clonal expansion, and HIV-1 persistence in vivo
    Jack A. Collora, Delia Pinto-Santini, Siavash Pasalar, Neal G. Ravindra, Carmela Ganoza, Javier R. Lama, Ricardo Alfaro, Jennifer Chiarella, Serena Spudich, David van Dijk et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
94. Defective Viral Particles
    Carolina B. López · 2021 · Virology
95. Host variation in type I interferon signaling genes ( MX1 ), CCR5 Δ 32 , and MHC class I alleles in treated HIV+ non-controllers predict viral reservoir size
    David A. Siegel, Cassandra Thanh, Eunice Wan, Rebecca Hoh, Kristen S. Hobbs, Tony Pan, Erica A. Gibson, Deanna L. Kroetz, Peter W. Hunt, Jeffrey N. Martin et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
96. Differences in expression of tumor suppressor, innate immune, inflammasome, and potassium/gap junction channel host genes significantly predict viral reservoir size during treated HIV infection
    Ashok K. Dwivedi, David A. Siegel, Cassandra Thanh, Rebecca Hoh, Kristen S. Hobbs, Tony Pan, Erica A. Gibson, Jeffrey N. Martin, Frederick M. Hecht, Christopher D. Pilcher et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
97. IFIH1 (MDA5) is required for innate immune detection of intron-containing RNA expressed from the HIV-1 provirus
    Mehmet Hakan Guney, Karthika Nagalekshmi, Sean Matthew McCauley, Claudia Carbone, Özkan Aydemir, Jeremy Luban · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
98. Differences in HIV-1 reservoir size, landscape characteristics and decay dynamics in acute and chronic treated HIV-1 Clade C infection
    Kavidha Reddy, Guinevere Q. Lee, Nicole Reddy · 2024 · eLife
99. Variability in HIV-1 transmitted/founder virus susceptibility to combined APOBEC3F and APOBEC3G host restriction
    Amit Gaba, Maria Yousefi, Shreoshri Bhattacharjee, Linda Chelico · 2024 · Journal of Virology
100. The role of Nef in the long-term persistence of the replication-competent HIV reservoir in South African women
     Sherazaan D. Ismail, Shorok Sebaa, Bianca Abrahams, Martha Nason, Mitchell J. Mumby, Jimmy Dimitrios Dikeakos, Sarah Joseph, Matthew Moeser, Ronald I. Swanstrom, Nigel Garrett et al. · 2025 · Journal of Virology